-
公开(公告)号:CZ9703258A3
公开(公告)日:1998-03-18
申请号:CZ325897
申请日:1996-04-10
Applicant: GLAXO WELLCOME INC
Inventor: ASHURST IAN C , HERMAN CRAIG S , LI-BOVET LI , RIEBE MICHAEL T
IPC: A61K9/12 , A61K31/56 , A61K31/569 , A61M15/00 , A61M15/08 , A61M16/00 , A61P11/00 , B05D5/00 , B05D5/08 , B65D83/14
CPC classification number: B65D83/54 , A61M15/009 , A61M2205/0222
-
公开(公告)号:TR9701170T1
公开(公告)日:1998-02-21
申请号:TR9701170
申请日:1996-04-11
Applicant: GLAXO WELLCOME INC
Inventor: ASHURST IAN C , HERMAN CRAIG S , LI-BOVET LI , RIEBE MICHAEL THOMAS
IPC: B65D83/38 , A61K9/00 , A61K9/12 , A61K9/72 , A61K31/137 , A61K31/57 , A61K31/573 , A61M15/00 , A61P11/00 , B05D5/08 , B65D83/14
CPC classification number: A61K9/008 , A61K31/573 , A61M15/009 , A61M2205/0222 , B65D83/54 , B65D83/752
-
公开(公告)号:NO974738L
公开(公告)日:1997-12-11
申请号:NO974738
申请日:1997-10-13
Applicant: GLAXO WELLCOME INC
Inventor: ASHURST IAN C , HERMAN CRAIG S , LI-BOVET LI , RIEBE MICHAEL T
IPC: B65D83/38 , A61K9/00 , A61K9/12 , A61K9/72 , A61K31/137 , A61K31/57 , A61K31/573 , A61M15/00 , A61P11/00 , B05D5/08 , B65D83/14
Abstract: A metered dose inhaler having part or all of its internal surfaces coated with one or more fluorocarbon polymers, optionally in combination with one or more non-fluorocarbon polymers, for dispensing an inhalation drug formulation comprising beclomethasone dipropionate or a physiologically acceptable solvate thereof, and a fluorocarbon propellant, optionally in combination with one or more other pharmacologically active agents or one or more excipients.
-
公开(公告)号:NO974735A
公开(公告)日:1997-12-11
申请号:NO974735
申请日:1997-10-13
Applicant: GLAXO WELLCOME INC
Inventor: ASHURST IAN C , HERMAN CRAIG S , LI-BOVET LI , RIEBE MICHAEL T
IPC: A61K9/12 , A61M15/00 , A61K31/56 , A61K31/569 , A61M15/08 , A61M16/00 , A61P11/00 , B05D5/00 , B05D5/08 , B65D83/14
CPC classification number: B65D83/54 , A61M15/009 , A61M2205/0222
-
公开(公告)号:NO974736D0
公开(公告)日:1997-10-13
申请号:NO974736
申请日:1997-10-13
Applicant: GLAXO WELLCOME INC
Inventor: ASHURST IAN C , HERMAN CRAIG S , LI-BOVET LI , RIEBE MICHAEL T
Abstract: A metered dose inhaler characterised in that part or all of its internal surfaces are coated with a polymer blend of one or more fluorocarbon polymers in combination with one or more non-fluorocarbon polymers, for dispensing an inhalation drug formulation comprising salmeterol, or a physiologically acceptable salt thereof, and a fluorocarbon propellant, optionally in combination with one or more other pharmacologically active agents or one or more excipients, wherein a) the fluorocarbon polymer is selected from the group consisting of PTFE, PFA, FEP and mixtures thereof, b) the non-fluorocarbon polymer is selected from the group consisting of polyamideimides, polyimides, polyethersulfones, polyphenylene sulfides and amine-formaldehyde thermosetting resins, (c) the inhaler comprises a can made of metal whose interior surfaces are coated with the polymer blend.
-
公开(公告)号:NO974735D0
公开(公告)日:1997-10-13
申请号:NO974735
申请日:1997-10-13
Applicant: GLAXO WELLCOME INC
Inventor: ASHURST IAN C , HERMAN CRAIG S , LI-BOVET LI , RIEBE MICHAEL T
IPC: A61K9/12 , A61K31/56 , A61K31/569 , A61M15/00 , A61M15/08 , A61M16/00 , A61P11/00 , B05D5/00 , B05D5/08 , B65D83/14 , A61M
Abstract: A metered dose inhaler having part or all of its internal surfaces coated with one or more fluorocarbon polymers, optionally in combination with one or more non-fluorocarbon polymers, for dispensing an inhalation drug formulation comprising fluticasone propionate, or a physiologically acceptable solvate thereof, and a fluorocarbon propellant optionally in combination with one or more other pharmacologically active agents or one or more excipients.
-
公开(公告)号:SK39397A3
公开(公告)日:1997-10-08
申请号:SK39397
申请日:1995-09-27
Applicant: GLAXO WELLCOME INC
Inventor: LI-BOVET LI , JOHNSON KEITH A
Abstract: A pharmaceutical aerosol formulation which comprises particulate medicament, a fluorocarbon of hydrogen-containing chlorofluorocarbon propellant and a surfactant of general formula (I), wherein n is an integer of 1 to 18; m is an integer of 0 to 17; and R1, R2 and R3 are each independently a hydrogen atom or a C1-4alkyl group. Said aerosol formulation is suitable for administration into the lungs or nasal cavity of a patient.
-
公开(公告)号:CZ9700936A3
公开(公告)日:1997-08-13
申请号:CZ93697
申请日:1995-09-27
Applicant: GLAXO WELLCOME INC
Inventor: LI-BOVET LI , JOHNSON KEITH ARTHUR
CPC classification number: A61K9/008 , C07F9/10 , Y10S514/975
-
公开(公告)号:IS4438A
公开(公告)日:1997-03-10
申请号:IS4438
申请日:1997-03-10
Applicant: GLAXO WELLCOME INC
Inventor: LI-BOVET LI , JOHNSON KEITH ARTHUR
-
公开(公告)号:AU3532195A
公开(公告)日:1996-04-19
申请号:AU3532195
申请日:1995-09-27
Applicant: GLAXO WELLCOME INC
Inventor: LI-BOVET LI , JOHNSON KEITH ARTHUR
Abstract: PCT No. PCT/IB95/00866 Sec. 371 Date Mar. 27, 1997 Sec. 102(e) Date Mar. 27, 1997 PCT Filed Sep. 27, 1995 PCT Pub. No. WO96/09816 PCT Pub. Date Apr. 4, 1996 (I) A pharmaceutical aerosol formulation which comprises particulate medicament, a fluorocarbon of hydrogen-containing chlorofluorocarbon propellant and a surfactant of general formula (I), wherein n is an integer of 1 to 18; m is an integer of 0 to 17; and R1, R2 and R3 are each independently a hydrogen atom or a C1-4alkyl group.
-
-
-
-
-
-
-
-
-